Cu Nguyen

National Cancer Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index2.5kcitations42works14.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(13), Genomics and Rare Diseases(7), Renal and related cancers(7), RNA modifications and cancer(5), Genomics and Phylogenetic Studies(4)

Publications41 total

Modular and cloud-based bioinformatics pipelines for high-confidence biomarker detection in cancer immunotherapy clinical trials
PLoS ONE·2025Open Access
Evaluation of somatic copy number variation detection by NGS technologies and bioinformatics tools on a hyper-diploid cancer genome
Genome biology·2024· 29 citedOpen Access
Cohesin regulates alternative splicing
Science Advances·2023· 23 citedOpen Access
Molecular Characterization of the Highest Risk Adult Patients With Acute Myeloid Leukemia (AML) Through Multi-Omics Clustering
Frontiers in Genetics·2021· 3 citedOpen Access
A comprehensive map of alternative polyadenylation in African American and European American lung cancer patients
Nature Communications·2021· 22 citedOpen Access
Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing
Nature Biotechnology·2021· 195 citedOpen Access
Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing
Nature Biotechnology·2021· 136 citedOpen Access
A community challenge to evaluate RNA-seq, fusion detection, and isoform quantification methods for cancer discovery
Cell Systems·2021· 36 citedOpen Access
Comprehensive Assessment of Somatic Copy Number Variation Calling Using Next-Generation Sequencing Data
2021· 10 citedOpen Access
Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network
Clinical Cancer Research·2020· 14 citedOpen Access
Long Non-Coding RNAs (lncRNAs) Are Highly Associated with Disease Characteristics and Outcome in Pediatric Acute Myeloid Leukemia - a COG and Tpaml Study
Blood·2019· 2 cited
Comprehensive Transcriptome Profiling of Cryptic <i>CBFA2T3–GLIS2</i> Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study
Clinical Cancer Research·2019· 74 citedOpen Access
Abstract 3521: Critical Assessment of CNV Calling Using Next Generation Sequencing
Cancer Research·2019
Establishing reference samples for detection of somatic mutations and germline variants with NGS technologies
2019· 7 citedOpen Access
Comparing the performance of selected variant callers using synthetic data and genome segmentation
BMC Bioinformatics·2018· 53 citedOpen Access
Altered Transcriptome Uniquely Associated with AML Vs. Normal Hematopoiesis
Blood·2017· 1 cited
A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor
Nature Genetics·2017· 362 citedOpen Access
Utilization of Next-Generation Deep Sequencing to Analyze BCR-ABL1 Kinase Domain Mutation for Imatinib-Resistant Chronic Myeloid Leukemia Patients in Vietnam
Journal of Leukemia·2017· 1 cited
Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study
PLoS Medicine·2016· 236 citedOpen Access
Comprehensive Clinical Genomic Profiling Defines Age-Associated Molecular Targets in Pediatric and Adult Acute Myeloid Leukemia
Blood·2016· 1 cited
page 1 of 3Next →

Frequent Co-authors

Daoud Meerzaman(29), Chunhua Yan(19), Qingrong Chen(17), Ying Hu(11), Chih Hao Hsu(9), Daniela S. Gerhard(8), Malcolm A. Smith(7), Samantha Gadd(6), Jaime M. Guidry Auvil(6), Charles G. Mullighan(6), David A. Wheeler(6), Nicole Ross(6), Elizabeth J. Perlman(6), Wenming Xiao(6), Robert Clifford(6), Kenneth H. Buetow(6), Soheil Meshinchi(6), Vicki Huff(5), Qing-Rong Chen(5), Yussanne Ma(5)